Self‐Assembled Antibody‐Oligonucleotide Conjugates for Targeted Delivery of Complementary Antisense Oligonucleotides
Angewandte Chemie International Edition · 15.01.2025 · 64 (3)
DOI: 10.1002/anie.202415272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 06.11.2024. Verfasst von Liujuan Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Assembly Medicine, LLC, Shanghai, 201203, China. Hauptthemen laut MEDLINE: Oligonucleotides, Antisense, Immunoconjugates, Antibodies. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 73 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Antibody‐oligonucleotide conjugate (AOC) affords preferential cell targeting and enhanced cellular uptake of antisense oligonucleotide (ASO). Here, we have developed a modular AOC (MAOC) approach based on accurate self‐assembly of separately prepared antibody and ASO modules. Homogeneous multimeric AOC with defined ASO‐to‐antibody ratio were generated by L–DNA scaffold mediated precise self‐assembly of antibodies and ASOs. The MAOC approach has been implemented to deliver exon skipping ASOs via transferrin receptor (TfR1) mediated internalization. We discovered an anti‐TfR1 sdAb that can greatly enhance nuclear delivery of ASOs. Cryo‐EM structure of the sdAb‐TfR1 complex showed a new epitope that does not overlap with the binding sites of endogenous TfR1 ligands. In vivo functional analyses of MAOCs with one ASO for single exon skipping and two ASOs for double exon skipping showed that both ASO concentration and exon skipping efficacy of MAOC in cardiac and skeletal muscles are dramatically higher than conventional ASOs in the transgenic human TfR1 mouse model. MAOC treatment was well tolerated in vivo and not associated with any toxicity‐related morbidity or mortality. Collectively, our data suggest that the self‐assembled MAOC is a viable option for broadening the therapeutic application of ASO via multi‐specific targeting and delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Assembly Medicine, LLC, Shanghai, 201203, China.
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
- Department of Pathology of Sir Run Run Shaw Hospital, and Department of Biophysics, Zhejiang University School of Medicine, Hangzhou, 310058, China.
- Center of Cryo Electron Microscopy, Zhejiang University School of Medicine, Hangzhou, 310058, China.
- Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, State Key Laboratory of Chemical Biology, Chinese Academy of Sciences, Shanghai, 201203, China.
- State Key Laboratory of Chemical Biology, Chinese Academy of Sciences, Shanghai, 201203, China.
ORCID-Profile: Liqiang Pan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, L., Bi, J., Chang, S., Bai, Z., Yu, J., Wang, R., Li, Z., Zhang, X., Chou, J. J., & Pan, L. (2025). Self‐Assembled Antibody‐Oligonucleotide Conjugates for Targeted Delivery of Complementary Antisense Oligonucleotides. Angewandte Chemie International Edition, 64(3). https://doi.org/10.1002/anie.202415272
Vancouver
Zhou L, Bi J, Chang S, Bai Z, Yu J, Wang R, et al. Self‐Assembled Antibody‐Oligonucleotide Conjugates for Targeted Delivery of Complementary Antisense Oligonucleotides. Angewandte Chemie International Edition. 2025;64(3). doi:10.1002/anie.202415272
BibTeX
@article{Zhou2025,
author = {Zhou, Liujuan and Bi, Jie and Chang, Shenghai and Bai, Zhaoshuai and Yu, Junqi and Wang, Ruru and Li, Zhihang and Zhang, Xing and Chou, James J and Pan, Liqiang},
title = {Self‐Assembled Antibody‐Oligonucleotide Conjugates for Targeted Delivery of Complementary Antisense Oligonucleotides},
journal = {Angewandte Chemie International Edition},
year = {2025},
volume = {64},
number = {3},
doi = {10.1002/anie.202415272}
}
EUVIMED